Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Onyx Biotec Limited (NSE: ONYX), ISIN INE0WVU01018 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
ONYX last traded at ₹34.60 (-1.14%), with a 52-week range of ₹24.20 to ₹49.65 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 41.74%, FIIs 0.22%, DIIs 2.39%, mutual funds 0.00%.
EquiSense Score (ECS): 43/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.